NDC 17856-6836-05 - loperamide hydrochloride

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
17856-6836
Requested NDC
17856-6836-05
Package NDCs from labels
17856-6836-3, 17856-6836-1, 17856-6836-4, 17856-6836-2, 17856-6836-5, 17856-6836-05
Manufacturer
ATLANTIC BIOLOGICALS CORP.
Effective date
2026-10-23
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Loperamide Hydrochloride Oral Solution Drug FactsATLANTIC BIOLOGICALS CORP.2026-10-23HUMAN OTC DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
17856-6836-12024-04-22Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12024-04-22Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12024-04-22Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22024-04-22Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22024-04-22Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22024-04-22Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12024-01-30Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12024-01-30Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12024-01-30Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22024-01-30Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22024-01-30Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22024-01-30Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12022-09-21Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12022-09-21Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12022-09-21Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22022-09-21Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22022-09-21Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22022-09-21Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12022-01-28Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12022-01-28Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-12022-01-28Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22022-01-28Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22022-01-28Loperamide Hydrochloride Oral Solution Drug Facts
17856-6836-22022-01-28Loperamide Hydrochloride Oral Solution Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17856-6836-1loperamide hydrochloride72 in 1 BOX, UNIT-DOSESOLUTION724
17856-6836-2loperamide hydrochloride50 in 1 BOX, UNIT-DOSESOLUTION504
17856-6836-3loperamide hydrochloride7.5 mL in 1 CUP, UNIT-DOSESOLUTION7.54
17856-6836-4loperamide hydrochloride15 mL in 1 CUP, UNIT-DOSESOLUTION154

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17856-6836LOPERAMIDE HYDROCHLORIDE (LOPERAMIDE HCL) SOLUTION [ATLANTIC BIOLOGICALS CORP.]4Current NDC, Legacy NDC, 4 package rows20250514_7030f4ed-3cd1-428e-9cae-3b14933d41f5.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
17856-6836-1ML - Milliliter17856-6836af7d0ad5-9b7d-4d75-ba3c-a88a12f26f3012022-11-07

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 210 · 4,189 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Family Wellness HEMORRHOIDGLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCLFAMILY DOLLAR (Family Wellness)16ceb129-5c0a-428a-a867-cfbbb08bb62a2026-10-26WarningsExact identifier
unii: PDC6A3C0OX
HERA SILKYSTAY FOUNDATION 26N1TITANIUM DIOXIDEAmorepacific Corporation5ec7151e-4f83-4aca-e063-6294a90a98182026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 26W1TITANIUM DIOXIDEAmorepacific Corporation5ec7276d-fcaf-65b2-e063-6394a90ac2202026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28C1TITANIUM DIOXIDEAmorepacific Corporation5ec73566-5d67-7153-e063-6394a90aba332026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28N1TITANIUM DIOXIDEAmorepacific Corporation5ec75100-153c-80cd-e063-6294a90a6d512026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28O1TITANIUM DIOXIDEAmorepacific Corporation5ec77f7a-4621-ac0c-e063-6294a90a3f702026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 29N1TITANIUM DIOXIDEAmorepacific Corporation5ec7ab15-9cc1-d53a-e063-6294a90a41112026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 29W1TITANIUM DIOXIDEAmorepacific Corporation5ec83b87-08bc-7590-e063-6294a90a0b782026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31C1TITANIUM DIOXIDEAmorepacific Corporation5ec857a3-7fd1-6461-e063-6394a90aacd72026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31N1TITANIUM DIOXIDEAmorepacific Corporation5ec871dc-f74e-765c-e063-6394a90a27a52026-10-26WarningsExact identifier
unii: 15FIX9V2JP
Bacteriostatic WaterWATERHenry Schein, Inc.a833502e-a622-4e81-8c58-cef6ccb6c4c92026-10-26Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 059QF0KO0R
HERA SILKYSTAY FOUNDATION 13N1TITANIUM DIOXIDEAmorepacific Corporation5eb19976-6983-3d9e-e063-6394a90a01ee2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
OptaseGLYCERINScope Health Incd81c1a4f-87b0-ee8c-e053-2995a90af9e52026-10-25WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc9e96976b-2990-79e0-e053-2995a90a0f292026-10-25WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc376e0289-28e9-e87f-e063-6294a90a3b042026-10-25WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Incf452a2c4-c869-7bf5-e053-2995a90ac1a02026-10-25WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc10c3e31d-779d-8ff6-e063-6294a90acd392026-10-25WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc86c14327-ffc7-806e-e053-2991aa0aaf922026-10-25WarningsExact identifier
unii: PDC6A3C0OX
HERA SILKYSTAY FOUNDATION 17C2TITANIUM DIOXIDEAmorepacific Corporation5eb338c7-e99c-887d-e063-6394a90a977c2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17N1TITANIUM DIOXIDEAmorepacific Corporation5eb363fe-c2b2-9381-e063-6294a90ad0382026-10-25WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.